MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20

• Main Authors: USATOVA, Veronika Sergeevna, TRUDOVISHNIKOVA, Anna Alexandrovna, KOSKOVA, Svetlana Vladimirovna, USTIUGOV, Iakov Iurevich, PESTOVA, Natalia Eugenievna, MISORIN, Alexey Konstantinovich, SOLOVYEV, Valery Vladimirovich, EROSHOVA, Anna Vladimirovna, DIDUK, Sergei Vasilyevich, SHELEVA, Mariia Aleksandrovna, ANIKINA, Arina Vitalevna, KHARATIAN, Nina Grachyaevna, IAKOVLEV, Pavel Andreevich, KRENDELEVA, Elena Andreevna, MOROZOV, Dmitry Valentinovich, ALEKSANDROV, Aleksei Aleksandrovich, IVANOV, Roman Alekseevich, SMIRNOVA, Iana Andreevna
• Format: Patent
• Language: English
• Published: 04.10.2021
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

The present invention relates to the field of bioengineering, and proposes a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA that codes for said antibody, the corresponding expression vectors and methods of production, as well as to treatment methods using said antibody.